Jove
Visualize
Contact Us
JoVE
x logofacebook logolinkedin logoyoutube logo
ABOUT JoVE
OverviewLeadershipBlogJoVE Help Center
AUTHORS
Publishing ProcessEditorial BoardScope & PoliciesPeer ReviewFAQSubmit
LIBRARIANS
TestimonialsSubscriptionsAccessResourcesLibrary Advisory BoardFAQ
RESEARCH
JoVE JournalMethods CollectionsJoVE Encyclopedia of ExperimentsArchive
EDUCATION
JoVE CoreJoVE BusinessJoVE Science EducationJoVE Lab ManualFaculty Resource CenterFaculty Site
Terms & Conditions of Use
Privacy Policy
Policies

Filters

A Lassiter

Showing results (21-30 of 33) with videos related to

Pageof 4
Sort By:
Pediatric Research|April 1, 1994
Supplemental complement component C9 enhances the capacity of neonatal serum to kill multiple isolates of pathogenic Escherichia coliH A Lassiter, J L Wilson, R C Feldhoff, et al.
The American Journal of Pediatric Hematology/Oncology|February 1, 1993
Neonatal immune neutropenia following the administration of intravenous immune globulinH A Lassiter, K W Bibb, S J Bertolone, et al.
The Journal of Pediatrics|April 1, 1991
Effect on neutrophil kinetics and serum opsonic capacity of intravenous administration of immune globulin to neonates with clinical signs of early-onset sepsisR D Christensen, M S Brown, D C Hall, et al.
The American Journal of the Medical Sciences|September 26, 2001
Nonspecific human IgG reduces survival in neonatal rats infected with Escherichia coliC W Cole, R C Feldhoff, L J Goldsmith, et al.
Journal of Perinatology : Official Journal of the California Perinatal Association|March 1, 1990
Complement C3 deposition onto bacteria by neonatal serum is not enhanced after the infusion of intravenous immunoglobulinH A Lassiter, M J Speranza, R T Hall, et al.
The American Journal of the Medical Sciences|May 20, 1998
Complement component C9 enhances the capacity of beta-lactam antibiotics to kill Escherichia coli in vitro and in vivoE Jung, R C Feldhoff, B M Walz, et al.
Journal of Perinatology : Official Journal of the California Perinatal Association|September 1, 1996
Effect of intravenous immunoglobulin G on the deposition of immunoglobulin G and C3 onto type III group B streptococcus and Escherichia coli K1H A Lassiter, T W Robinson, M S Brown, et al.
Neuroscience Letters|August 27, 2005
Effects of endotoxin administration and cerebral hypoxia-ischemia on complement activity and local transcriptional regulation in neonatal ratsLori A Devlin, Mai-Dung T Nguyen, Estuardo Figueroa, et al.
Annals of Translational Medicine|October 30, 2019
Intravenous cangrelor as a peri-procedural bridge with applied uses in ischemic eventsVenugopal B Bhattad, Sathvika Gaddam, Margaret A Lassiter, et al.
American Journal of Perinatology|April 25, 2009
The role of complement in neurodevelopmental impairment following neonatal hypoxic-ischemic encephalopathyHany Aly, Mohamed T Khashaba, Ayman Nada, et al.
Pageof 4

Showing results (21-30 of 33) with videos related to

Sort By:
Pageof 4
Pediatric Research|April 1, 1994
Supplemental complement component C9 enhances the capacity of neonatal serum to kill multiple isolates of pathogenic Escherichia coliH A Lassiter, J L Wilson, R C Feldhoff, et al.
The American Journal of Pediatric Hematology/Oncology|February 1, 1993
Neonatal immune neutropenia following the administration of intravenous immune globulinH A Lassiter, K W Bibb, S J Bertolone, et al.
The Journal of Pediatrics|April 1, 1991
Effect on neutrophil kinetics and serum opsonic capacity of intravenous administration of immune globulin to neonates with clinical signs of early-onset sepsisR D Christensen, M S Brown, D C Hall, et al.
The American Journal of the Medical Sciences|September 26, 2001
Nonspecific human IgG reduces survival in neonatal rats infected with Escherichia coliC W Cole, R C Feldhoff, L J Goldsmith, et al.
Journal of Perinatology : Official Journal of the California Perinatal Association|March 1, 1990
Complement C3 deposition onto bacteria by neonatal serum is not enhanced after the infusion of intravenous immunoglobulinH A Lassiter, M J Speranza, R T Hall, et al.
The American Journal of the Medical Sciences|May 20, 1998
Complement component C9 enhances the capacity of beta-lactam antibiotics to kill Escherichia coli in vitro and in vivoE Jung, R C Feldhoff, B M Walz, et al.
Journal of Perinatology : Official Journal of the California Perinatal Association|September 1, 1996
Effect of intravenous immunoglobulin G on the deposition of immunoglobulin G and C3 onto type III group B streptococcus and Escherichia coli K1H A Lassiter, T W Robinson, M S Brown, et al.
Neuroscience Letters|August 27, 2005
Effects of endotoxin administration and cerebral hypoxia-ischemia on complement activity and local transcriptional regulation in neonatal ratsLori A Devlin, Mai-Dung T Nguyen, Estuardo Figueroa, et al.
Annals of Translational Medicine|October 30, 2019
Intravenous cangrelor as a peri-procedural bridge with applied uses in ischemic eventsVenugopal B Bhattad, Sathvika Gaddam, Margaret A Lassiter, et al.
American Journal of Perinatology|April 25, 2009
The role of complement in neurodevelopmental impairment following neonatal hypoxic-ischemic encephalopathyHany Aly, Mohamed T Khashaba, Ayman Nada, et al.
Pageof 4